In the future, with the in-depth exploration of the mechanism of GLP-1R action and the development of multi-target agonists (e.g., GLP-1R/GIPR dual agonists), GLP-1R-related therapeutics are expected to make breakthroughs in a wider range of disease areas (e.g., nonalcoholic steatohepatitis, AD, etc.), providing a more precise and highly effective strategy for the treatment of metabolic diseases and related complications
To improve the chance for any return on investment with GLP-1 use, there is an increased importance on the need for meaningful lifestyle changes alongside medication use
Low B12 levels can cause fatigue, weakness, shortness of breath, headaches, digestive changes, and other symptoms
The cream looks pinkish at first but it adapts to your face skin tone once applied
Using both provides dual cardiovascular protection, limits individual risk factors, and helps determine whether this matters for your treatment strategy